US Stock MarketDetailed Quotes

Senti Biosciences (SNTI)

Watchlist
  • 0.8804
  • -0.0597-6.35%
Close May 19 16:00 ET
  • 0.8823
  • +0.0019+0.22%
Post 18:41 ET
27.42MMarket Cap-0.60P/E (TTM)

Senti Biosciences (SNTI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
46.75%-7.48M
-4.94%-43.44M
49.09%-6.88M
-20.09%-9.45M
-56.66%-13.07M
-20.27%-14.05M
20.99%-41.4M
-91.90%-13.5M
48.85%-7.87M
38.98%-8.35M
Net income from continuing operations
70.09%-4.22M
-16.38%-61.44M
-2,271.64%-14.47M
37.21%-18.13M
-31.51%-14.73M
-16.52%-14.11M
25.71%-52.79M
96.74%-610K
-93.43%-28.87M
40.08%-11.2M
Operating gains losses
----
----
----
----
----
----
74.86%-6.33M
-104.63%-107K
---2.35M
----
Depreciation and amortization
-25.70%688K
-5.24%3.64M
-4.70%893K
-640.74%-200K
37.56%2.02M
-36.62%926K
-29.31%3.84M
-36.43%937K
-101.49%-27K
21.14%1.47M
Other non cash items
---6.71M
-99.32%39K
--0
--0
----
----
806.02%5.75M
-3,055.45%-13.32M
10,011.11%17.84M
3,043.90%3.62M
Change In working capital
169.92%1.45M
-41.36%3.56M
121.92%222K
60.90%7.33M
-179.43%-1.92M
-2,014.81%-2.07M
30.14%6.07M
-116.94%-1.01M
881.30%4.56M
175.11%2.42M
-Change in receivables
300.97%830K
129.49%210K
124.11%149K
8,569.57%1.95M
-1,033.85%-1.47M
-800.00%-413K
23.36%-712K
-153.09%-618K
98.93%-23K
-165.33%-130K
-Change in prepaid assets
193.85%183K
-58.04%3.72M
66.18%-1.07M
-27.02%3.02M
-53.37%1.97M
-105.30%-195K
84.71%8.86M
-194.83%-3.18M
186.37%4.14M
948.26%4.21M
-Change in payables and accrued expense
-190.68%-2.22M
1,726.98%2.3M
-56.45%1.42M
7,572.41%2.23M
5.03%-585K
70.20%-762K
-70.42%126K
182.87%3.27M
-93.79%29K
-266.94%-616K
-Change in other current assets
-16.61%452K
13.86%2.29M
15.90%605K
----
----
--542K
--2.01M
--522K
----
----
-Change in other current liabilities
122.69%248K
-19.71%-4.65M
-19.09%-1.23M
-29.32%-1.19M
-15.36%-1.13M
-15.54%-1.09M
-902.07%-3.88M
-378.92%-1.03M
0.00%-921K
-742.48%-983K
-Change in other working capital
1,425.17%1.95M
4.86%-313K
1,552.38%347K
-126.42%-360K
-139.06%-153K
-15.75%-147K
-199.09%-329K
136.21%21K
-127.27%-159K
73.66%-64K
Cash from discontinued investing activities
Operating cash flow
46.75%-7.48M
-4.94%-43.44M
49.09%-6.88M
-20.09%-9.45M
-56.66%-13.07M
-20.27%-14.05M
20.99%-41.4M
-91.90%-13.5M
48.85%-7.87M
38.98%-8.35M
Investing cash flow
Cash flow from continuing investing activities
114K
-641.18%-184K
0
0
-184K
0
-99.89%34K
-110.89%-11K
-99.72%60K
0
Net PPE purchase and sale
--114K
-641.18%-184K
--0
--0
---184K
--0
100.28%34K
-110.89%-11K
103.23%60K
--0
Net investment purchase and sale
----
----
----
----
----
----
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--114K
-641.18%-184K
--0
--0
---184K
--0
-99.89%34K
-110.89%-11K
-99.72%60K
--0
Financing cash flow
Cash flow from continuing financing activities
71.50%-118K
-78.11%11.76M
-78.48%11.04M
-94.92%124K
1.01M
-414K
6,797.30%53.73M
9,124.82%51.29M
10,708.70%2.44M
0
Net issuance payments of debt
----
----
----
----
----
----
--0
-10,465.22%-2.43M
10,665.22%2.43M
--0
Net common stock issuance
----
--0
-101.37%-670K
--136K
----
----
9,481.84%49.06M
23,948.53%49.06M
--0
----
Proceeds from stock option exercised by employees
----
--11.18M
111,900.00%11.18M
----
----
----
--0
---10K
----
----
Net other financing activities
71.50%-118K
-87.56%581K
-76.35%530K
---12K
--477K
---414K
--4.67M
--2.24M
----
----
Cash from discontinued financing activities
Financing cash flow
71.50%-118K
-78.11%11.76M
-78.48%11.04M
-94.92%124K
--1.01M
---414K
6,797.30%53.73M
9,124.82%51.29M
10,708.70%2.44M
--0
Net cash flow
Beginning cash position
-61.50%19.95M
31.35%51.82M
12.41%15.78M
29.37%25.11M
34.59%37.35M
31.35%51.82M
-35.32%39.45M
-69.36%14.04M
-51.59%19.41M
-21.05%27.75M
Current changes in cash
48.25%-7.49M
-357.68%-31.87M
-88.97%4.17M
-73.72%-9.32M
-46.75%-12.25M
-23.66%-14.46M
157.42%12.37M
692.08%37.78M
-193.48%-5.37M
-269.03%-8.35M
End cash Position
-66.63%12.46M
-61.50%19.95M
-61.50%19.95M
12.41%15.78M
29.37%25.11M
34.59%37.35M
31.35%51.82M
31.35%51.82M
-69.36%14.04M
-51.59%19.41M
Free cash flow
46.75%-7.48M
-5.35%-43.64M
49.13%-6.88M
-20.09%-9.45M
-59.01%-13.27M
-20.12%-14.05M
35.71%-41.42M
-91.95%-13.52M
54.37%-7.87M
51.89%-8.35M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 46.75%-7.48M-4.94%-43.44M49.09%-6.88M-20.09%-9.45M-56.66%-13.07M-20.27%-14.05M20.99%-41.4M-91.90%-13.5M48.85%-7.87M38.98%-8.35M
Net income from continuing operations 70.09%-4.22M-16.38%-61.44M-2,271.64%-14.47M37.21%-18.13M-31.51%-14.73M-16.52%-14.11M25.71%-52.79M96.74%-610K-93.43%-28.87M40.08%-11.2M
Operating gains losses ------------------------74.86%-6.33M-104.63%-107K---2.35M----
Depreciation and amortization -25.70%688K-5.24%3.64M-4.70%893K-640.74%-200K37.56%2.02M-36.62%926K-29.31%3.84M-36.43%937K-101.49%-27K21.14%1.47M
Other non cash items ---6.71M-99.32%39K--0--0--------806.02%5.75M-3,055.45%-13.32M10,011.11%17.84M3,043.90%3.62M
Change In working capital 169.92%1.45M-41.36%3.56M121.92%222K60.90%7.33M-179.43%-1.92M-2,014.81%-2.07M30.14%6.07M-116.94%-1.01M881.30%4.56M175.11%2.42M
-Change in receivables 300.97%830K129.49%210K124.11%149K8,569.57%1.95M-1,033.85%-1.47M-800.00%-413K23.36%-712K-153.09%-618K98.93%-23K-165.33%-130K
-Change in prepaid assets 193.85%183K-58.04%3.72M66.18%-1.07M-27.02%3.02M-53.37%1.97M-105.30%-195K84.71%8.86M-194.83%-3.18M186.37%4.14M948.26%4.21M
-Change in payables and accrued expense -190.68%-2.22M1,726.98%2.3M-56.45%1.42M7,572.41%2.23M5.03%-585K70.20%-762K-70.42%126K182.87%3.27M-93.79%29K-266.94%-616K
-Change in other current assets -16.61%452K13.86%2.29M15.90%605K----------542K--2.01M--522K--------
-Change in other current liabilities 122.69%248K-19.71%-4.65M-19.09%-1.23M-29.32%-1.19M-15.36%-1.13M-15.54%-1.09M-902.07%-3.88M-378.92%-1.03M0.00%-921K-742.48%-983K
-Change in other working capital 1,425.17%1.95M4.86%-313K1,552.38%347K-126.42%-360K-139.06%-153K-15.75%-147K-199.09%-329K136.21%21K-127.27%-159K73.66%-64K
Cash from discontinued investing activities
Operating cash flow 46.75%-7.48M-4.94%-43.44M49.09%-6.88M-20.09%-9.45M-56.66%-13.07M-20.27%-14.05M20.99%-41.4M-91.90%-13.5M48.85%-7.87M38.98%-8.35M
Investing cash flow
Cash flow from continuing investing activities 114K-641.18%-184K00-184K0-99.89%34K-110.89%-11K-99.72%60K0
Net PPE purchase and sale --114K-641.18%-184K--0--0---184K--0100.28%34K-110.89%-11K103.23%60K--0
Net investment purchase and sale --------------------------0--0--0--0
Cash from discontinued investing activities
Investing cash flow --114K-641.18%-184K--0--0---184K--0-99.89%34K-110.89%-11K-99.72%60K--0
Financing cash flow
Cash flow from continuing financing activities 71.50%-118K-78.11%11.76M-78.48%11.04M-94.92%124K1.01M-414K6,797.30%53.73M9,124.82%51.29M10,708.70%2.44M0
Net issuance payments of debt --------------------------0-10,465.22%-2.43M10,665.22%2.43M--0
Net common stock issuance ------0-101.37%-670K--136K--------9,481.84%49.06M23,948.53%49.06M--0----
Proceeds from stock option exercised by employees ------11.18M111,900.00%11.18M--------------0---10K--------
Net other financing activities 71.50%-118K-87.56%581K-76.35%530K---12K--477K---414K--4.67M--2.24M--------
Cash from discontinued financing activities
Financing cash flow 71.50%-118K-78.11%11.76M-78.48%11.04M-94.92%124K--1.01M---414K6,797.30%53.73M9,124.82%51.29M10,708.70%2.44M--0
Net cash flow
Beginning cash position -61.50%19.95M31.35%51.82M12.41%15.78M29.37%25.11M34.59%37.35M31.35%51.82M-35.32%39.45M-69.36%14.04M-51.59%19.41M-21.05%27.75M
Current changes in cash 48.25%-7.49M-357.68%-31.87M-88.97%4.17M-73.72%-9.32M-46.75%-12.25M-23.66%-14.46M157.42%12.37M692.08%37.78M-193.48%-5.37M-269.03%-8.35M
End cash Position -66.63%12.46M-61.50%19.95M-61.50%19.95M12.41%15.78M29.37%25.11M34.59%37.35M31.35%51.82M31.35%51.82M-69.36%14.04M-51.59%19.41M
Free cash flow 46.75%-7.48M-5.35%-43.64M49.13%-6.88M-20.09%-9.45M-59.01%-13.27M-20.12%-14.05M35.71%-41.42M-91.95%-13.52M54.37%-7.87M51.89%-8.35M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 19 Eastern Time, Trump warned that Iran might only have a negotiating window until Sunday or early next week, adding that 'it may be Show More